DELAFIELD, Wis. (Stockpickr) -- Professional traders running mutual funds and hedge funds don't just look at a stock's price moves; they also track big changes in volume activity. Often when above-average volume moves into an equity, it precedes a large spike in volatility.
>>4 Big Stocks on Traders' Radars
Major moves in volume can signal unusual activity, such as insider buying or selling -- or buying or selling by "superinvestors."
Unusual volume can also be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst. These types of traders like to get in well before a large spike, so it's always a smart move to monitor unusual volume. That said, remember to combine trend and price action with unusual volume. Put them all together to help you decipher the next big trend for any stock. >>5 Low-Priced Stocks to Trade for Gains With that in mind, let's take a look at several stocks rising on unusual volume recently.
Top 5 Net Payout Yield Companies To Watch For 2015: Time Inc (TIME)
Time Inc., incorporated on September 28, 1988, is a magazine publisher in the United States. As of March 31, 2014, the Company publishes 23 magazines in print in the United States, including People, Sports Illustrated, InStyle, Time, Real Simple, Southern Living, Entertainment Weekly and Fortune and over 70 magazines outside the United States, primarily through IPC Magazines Group Limited (IPC) in the United Kingdom and Grupo Editorial Expansion (GEX) in Mexico. On April 30, 2014, the Company acquired the IPC publishing business in the United Kingdom, which was previously owned by a wholly-owned subsidiary of Time Warner (the IPC Purchase). In June 2014, Time Inc acquired Cozi Inc., a Seattle-based technology company with a portfolio of mobile and digital family organizing tools
The Company�� United States and United Kingdom print magazines is also available as tablet editions on digital devices and platforms. In addition, as of March 31, 2014, it operated over 45 Websites that collectively have tens of millions of average monthly visitors globally. It also operates an integrated publishing business that provides content marketing, targeted local print and digital advertising programs, branded book publishing and marketing and support services, including magazine subscription sales services, retail distribution and marketing services and customer service and fulfillment services, to the Company and other third-party clients, including other magazine publishers.
Advisors' Opinion:- [By Chris Isidore]
With a circulation of 931,558, Forbes is the No. 3 U.S. business publication, behind Time Inc.'s (TIME) Money magazine and Bloomberg Businessweek. It is particularly well known for its lists such as the world's richest people. Forbes Media also has an online presence in Forbes.com, and a majority stake in the Real Clear group of Web sites, such as Real Clear Politics.
- [By Paul Vigna]
Time Inc.(TIME), the former Time Warner Inc.(TWX) publishing business, lowered its full-year revenue outlook, as the company looks to counteract weakness in print advertising. Shares were inactive premarket.
- [By Vera Yuan]
During the quarter we initiated a position in Publicis (1.0%), and exited the last of our position in Admiral. We added further to the recently initiated position in Time Warner (TWX)(3.6%), partly funded by selling a small position in Time Inc. (TIME), the magazine business spun off from the parent. We also added to and reduced select Consumer Staples, Information Technology, Industrial and Financials names.
10 Best Managed Healthcare Stocks For 2014: Tonix Pharmaceuticals Holding Corp (TNXP)
Tonix Pharmaceuticals Holding Corp., incorporated on November 16, 2011, is a specialty pharmaceutical company focused on developing novel pharmaceutical products for disorders of the central nervous system (CNS). The Company develops TNX-102 sublingual tablet, or TNX-102 SL. TNX-102 SL is a novel dose and formulation of cyclobenzaprine (CBP), the active pharmaceutical ingredient of two prescribed muscle relaxant products, Flexeril and Amrix. TNX-102 SL is also intended for chronic use. It develops TNX-102 SL for the treatment of FM under a United States Investigational New Drug application (IND), and under three clinical trial applications (CTAs), filed in Canada. It also develops TNX-102 SL for the treatment of post-traumatic stress disorder (PTSD). As of January 25, 2013, the Company focuses on product development, and had not generated any revenues.
The Company searches for potential therapeutic solutions among known pharmaceutical agents that lack regulatory approval for the indications it seeks, but may be approved for use in other indications. It seeks to create new dose and formulation options that are tailored to the therapeutic uses to which it applies these agents. TNX-102 SL is a small, rapidly disintegrating tablet containing CBP for sublingual administration at bedtime. The Company designed TNX-102 SL for delivery of CBP to the systemic circulation through sublingual transmucosal absorption and to avoid first-pass liver metabolism.
CBP is the active pharmaceutical ingredient in its lead product candidate, TNX-102 SL. In addition to CBP, TNX-102 SL contains inactive ingredients, called excipients, which are approved for pharmaceutical use. In addition to TNX-102 SL, it develops other formulations of CBP, including TNX-102 promicellar gelatin capsule, or TNX-102 gelcap. It developed TNX-102 gelcap under an agreement with Lipocine, Inc. (Lipocine), a contract formulation developer and small-scale manufacturer. In addition it has other pipeline of other product cand! idates, including TNX-201 and TNX-301. TNX-201 is based on isometheptene mucate and is under development as a treatment for certain types of headaches.
Advisors' Opinion:- [By John Kell]
Tonix Pharmaceuticals Holding Corp.(TNXP) is planning to offer some shares to raise money to fund clinical trials and the continued development of the specialty pharmaceutical company’s treatments. Shares edged up 2.1% to $16.75 premarket.
- [By John Udovich]
It�� a new year and the first one and a half trading weeks of 2014 has not disappointed biotech investors as the sector and mid cap or small cap biotech or�pharma stocks like Intercept Pharmaceuticals Inc (NASDAQ: ICPT), Epizyme Inc (NASDAQ: EPZM), Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) and TNI BioTech Inc (OTCQB: TNIB) either surging or producing some news plus there have been IPO filings for future listings for�Flexion Therapeutics (NASDAQ: FLXN), Aldexa Therapeutics (NASDAQ: ALDX), Retrophin (NASDAQ:�RTRX) and Dicerna Pharmaceuticals (NASDAQ: DRNA). Consider the following news so far this year:
10 Best Managed Healthcare Stocks For 2014: Sigma-Aldrich Corp (SIAL)
Sigma-Aldrich Corporation, incorporated in May 12, 1975, is a life science and high technology company. The Company develops, manufactures, purchases and distributes the range of chemicals, biochemicals and equipment available globally and also provides global biopharmaceutical testing services. These chemical products, kits and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. As of December 31, 2012, the Company offered approximately 45,000 equipment products. On January 31, 2012, the Company completed its acquisition of all of interest of BioReliance, a provider of global biopharmaceutical testing services. On April 2, 2012, the Company acquired Research Organics, a supplier of purity biochemicals.
The Company provides products and services that focus on research customers that use smaller quantities of its products in basic life science and high-technology research and development (R&D); manufacturing customers that use its products in quantities in lab-stage development and manufacturing; life science customers who use its biopharmaceutical testing services to facilitate the development, manufacturing and commercialization of biological drugs, and industrial and diagnostic companies that use its products in range of forms of assays and testing, as well as in clinical diagnostics. The Company has a customer base of commercial laboratories, pharmaceutical companies, industrial companies, universities, diagnostics companies, biotechnology companies, electronics companies, hospitals, governmental institutions and non-profit organizations located in the United States and globally.
Advisors' Opinion:- [By Garrett Cook]
Germany’s Merck KGaA (OTC: MKGAY) announced its plans to acquire Sigma-Aldrich (NASDAQ: SIAL) for $17 billion in cash.
The offer price of $140 per share represents a 37% premium to Sigma-Aldrich’s closing price of $102.37 on September 19.
- [By Maxx Chatsko]
Any company that creates products and relies on other companies to use and distribute them will inevitably forge strong relationships with its customers. It's an important thing to look into when investing, yet easy to overlook. Investors should know whether customers are reliable, which are leaned on the most, and if the company they own is too dependent on any customer (or a select few). Bioprocessing product company Repligen (NASDAQ: RGEN ) may make consumables that are the lifeline of the biotech industry, but its customer relationships are absolutely critical for smooth operations. Let's look at how the company interacts with the Life Sciences division of General Electric (NYSE: GE ) , EMD Millipore from Merck (NYSE: MRK ) , and Sigma-Aldrich (NASDAQ: SIAL ) -- the three most important customers.
- [By Monica Gerson]
Sigma-Aldrich (NASDAQ: SIAL) is expected to report its Q3 earnings at $0.99 per share on revenue of $661.29 million.
CR Bard (NYSE: BCR) is projected to post its Q3 earnings at $1.40 per share on revenue of $739.62 million.
- [By Vanina Egea]
At the beginning of April, the trade alarm for Sigma-Aldrich (SIAL) set off due to a larger seller coming together with the buyers to raise a posted offer. The phenomena pushed up stock face value, however unable to continue the previous trend. Hence, stock value has been on a decline since the month of March. Reasoning about the sources for the stagnation, will give potential investors important insight for a current or future investment. Given the nature of the firm, close attention should be paid to research and development. But, most importantly, to the business model as a whole and market environment. Looking at recent full year reports can also offer important information about specific performance indicators. In the middle, there is an important number of new positions consolidated by gurus through 2013, who would like to see new investors enter the business.
10 Best Managed Healthcare Stocks For 2014: Rayonier Inc. REIT(RYN)
Rayonier, Inc. engages in the sale and development of real estate and timberland management, as well as in the production and sale of cellulose fibers in the United States, New Zealand, and Australia. The company operates in four segments: Timber, Real Estate, Performance Fibers, and Wood Products. Timber segment owns, leases, or manages timberlands and sells standing timber at auction to third parties, as well as sells delivered logs. Real Estate segment sells medium and large tracts of land with infrastructure. This segment holds development and rural properties primarily in the southeast United States. Performance Fibers segment manufactures cellulose specialties that are used principally in acetate textile fibers, cigarette filters, rigid packaging, LCD screens, photographic film, impact-resistant plastics, high-tenacity rayon yarn, pharmaceuticals, cosmetics, detergents, food casings, and food products; and absorbent materials that are used in disposable baby diapers, feminine hygiene products, incontinence pads, convalescent bed pads, industrial towels and wipes, and nonwoven fabrics. Wood Products segment primarily manufactures and sells dimension lumber used for residential and industrial construction applications. In addition, Rayonier involves in trading and exporting logs, lumber, and wood panel products. As of December 31, 2005, it owned, leased, or managed approximately 2.5 million acres of timberland and real estate. The company has a joint venture with RREEF Infrastructure to own and manage timber lands in New Zealand. Rayonier has elected to be treated as a real estate investment trust (REIT) for federal income tax purposes and would not be subject to federal income tax on its REIT income that it distributes to its shareholders. The company, formerly known as Rainier Pulp & Paper Company, was founded in 1926. Rayonier is headquartered in Jacksonville, Florida.
Advisors' Opinion:- [By Saibus Research]
WY and the majority of the timber, forest and paper products companies have a track record of unimpressive returns on capital, cyclical revenue and profit trends, heavy use of capital expenditures, and significant environmental regulation. We also think that WY's conversion to a REIT was a mistake. Morningstar Investment Research's Timber, Forest and Paper Products analyst Dan Rohr said it best when he rated WY and its Timber REIT peers Rayonier (RYN), Potlatch (PCH) and Plum Creek (PCL) as not possessing any economic moat. That probably explains why we only have an ancillary exposure to this industry for our proprietary portfolio based on our holdings in Brookfield Infrastructure (BIP) and Cintas (CTAS). Brookfield's Timber segment only accounts for 5% of its Fund Flows from operations and Cintas's document management business is suffering from reduced prices on recycled paper. At least Cintas Document Management only accounts for 8% of Cintas's revenue.
- [By Jake L'Ecuyer]
Rayonier (NYSE: RYN) was also up, gaining 6.78 percent to $43.97 after the company reported Q4 results and announced its plans to separate into two public companies.
10 Best Managed Healthcare Stocks For 2014: Penn National Gaming Inc.(PENN)
Penn National Gaming, Inc. and its subsidiaries own and manage gaming and pari-mutuel properties in the United States. It operates approximately 27,000 gaming machines; 500 table games; and 2,000 hotel rooms in 23 facilities in 16 jurisdictions, including Colorado, Florida, Illinois, Indiana, Iowa, Louisiana, Maine, Maryland, Mississippi, Missouri, New Jersey, New Mexico, Ohio, Pennsylvania, West Virginia, and Ontario. The company was formerly known as PNRC Corp. and changed its name to Penn National Gaming, Inc. in 1994. Penn National Gaming, Inc. was founded in 1982 and is based in Wyomissing, Pennsylvania.
Advisors' Opinion:- [By Will Ashworth]
Although Penn National Gaming (PENN) completed the spinoff of its real estate assets on Nov. 1, 2013, Gaming and Leisure Properties��(GLPI) shares have traded since mid-October. The only pure-play Casino REIT was created to provide PENN shareholders with two investments: gaming and real estate. Both businesses would be able to focus on what they do best with shareholders better off as a result. I can�� argue with the rationale.
- [By Paul Ausick]
Penn National Gaming Inc. (NASDAQ: PENN) completed on Monday the spin-off of its real-estate holdings into a new REIT, Gaming and Leisure Properties Inc. (G&LP) (NASDAQ: GLPI). The spin-off was first announced a year ago. Shares in GLPI are trading at around $46.51 after opening at $45.76 this morning.
10 Best Managed Healthcare Stocks For 2014: Performant Financial Corp (PFMT)
Performant Financial Corporation (Performant), incorporated on October 8, 2003, provide technology-enabled recovery and related analytics services in the United States. The Company�� services help identify and recover delinquent or defaulted assets and improper payments for both government and private clients in a broad range of markets. The Company provides its services on an outsourced basis, where the Company handles many or all aspects of its clients��recovery processes. The Company derives its revenues from services for clients in a range of different markets. These markets include student lending and healthcare, as well as its other markets, which include delinquent state taxes and federal Treasury and other receivables. The Company�� clients include 12 of the 32 public sector participants in the student loan industry. In February 2012, it purchased a perpetual software license and computer equipment from HOPS, Inc.
Student Lending
The Company derives its revenues from the recovery of student loans. These revenues are contract-based and consist primarily of contingency fees based on a specified percentage of the amount the Company enables its clients to recover. The Company engages subcontractors to assist in the recovery of a portion of the client�� portfolio. It also receives success fees for the recovery of loans under Master Service Agreements (MSAs) and its revenues under MSA arrangements include fees earned by the activities of its subcontractors. The Company uses its technology to identify, track and communicate with defaulted borrowers on behalf of its clients to implement suitable recovery programs for the repayment of outstanding student loan balances.
The Company�� client�� contract with it to provide recovery services for large pools of student loans generally representing a portion of the total outstanding defaulted balances they manage, which they provide to us as placements on a periodic basis. The Company also restructures and r! ecovers student loans issued directly by banks to students outside of federal lending programs.
Healthcare
The Company derives revenues from the healthcare market primarily from its Recovery Audit Contractor (RAC), contract, under, which it is a prime contractor responsible for detecting improperly paid Part A and Part B Medicare claims in 12 states in the Northeastern United States. Revenues earned under the RAC contract are driven by the identification of improperly paid Medicare claims through both automated and manual review of such claims. The Company outsourced certain aspects of its healthcare recovery process to three different subcontractors.
Other
The Company derives revenues from the recovery of delinquent state taxes, and federal Treasury and other receivables, default aversion services for certain clients, including financial institutions and the licensing of hosted technology solutions to certain clients. For its hosted technology services, the Company licenses its system and integrates its technology into its clients��operations, for which it is paid a licensing fee. The Company�� revenues for these services include contingency fees, fees based on dedicated headcount to its clients and hosted technology licensing fees. The federal agency market consists of government debt subrogated to the Department of the Treasury.
For state and municipal tax authorities, the Company analyzes a portfolio of delinquent tax and other receivables placed with the Company, develop a recovery plan and execute a recovery process designed to maximize the recovery of funds. In some instances, it has also run state tax amnesty programs, which provide one-time relief for delinquent tax obligations, and other debtor management services for its clients. For the Department of the Treasury, it recovers government debt subrogated to it by numerous different federal agencies. The placements it has provided represent a mix of commercial and individual oblig! ations.
Data Management Expertise
The Company�� platform manages and stores large amounts of data throughout the workflow process. This includes both data it has compiled, as well as third-party data.
Data Analytics Capabilities
The Company�� data analytics capabilities screen and allocate massive volumes of recovery inventory. Upon receipt of each placement of student loans, the Company utilize its algorithms to assist its in determining the recovery process and the optimal allocation of recovery specialist resources for each loan. In the healthcare market, the Company analyze millions of Medicare claims to find potential correlations between claims data and improper payments.
Workflow Processes
The Company refers to the patented technology that supports its workflows as Smart Bins. The Company�� workflow processes integrate a range of functions that encompass each stage of a recovery process.
The Company competes with Health Management Systems, Inc., Connolly Consulting, Inc. and CGI Group.
Advisors' Opinion:- [By Magic Diligence]
Much of United Online's appeal was due to its over 4% dividend yield, but the company announced in late January that it would be discontinuing its dividend to focus on growth initiatives. This follows itsNovember spin-off of FTD, which leaves United with 3 cash producing but declining businesses: Classmates.com, NetZero, and Juno. NetZero Mobile Broadband is an interesting product but one with a lot of competition from the carriers. Frankly, the dividend has been the main attraction for some time, and without it this is a declining company with a fair bit of debt. That does not make for the most attractive option. PASS.
Performant Financial (PFMT) - down 28.1%Performant earns fees for collecting delinquent student loans (about 60% of the business) and providing recovery services for improper Medicare payments (close to 30%). The recent sell-off in the stock seems due to comments from Sallie Mae regarding lower rehabilitation fees paid to Guarantee Agencies, which investors expect to "trickle down" to service providers like PFMT. The stock has been sold off dramatically on these assumptions. We should know more when the company reports earnings in the coming weeks, but this is one worth looking at more closely - the firm has been growing revenue at 30%+ rates. WORTHY OF CONSIDERATION.
- [By Roberto Pedone]
Performant Financial (PFMT) provides technology-enabled recovery and related analytics services in the U.S. This stock closed up 6.9% at $11.84 in Friday's trading session.
Friday's Volume: 310,000
Three-Month Average Volume: 261,916
Volume % Change: 60%From a technical perspective, PFMT soared higher here right off both its 200-day moving average of $11.02 and its 50-day moving average at $11.06 with decent upside volume. This move is quickly pushing shares of PFMT within range of triggering a major breakout trade. That trade will hit if PFMT manages to take out some near-term overhead resistance levels at $12.47 to $13.26 with high volume.
Traders should now look for long-biased trades in PFMT as long as it's trending above its 200-day at $11.02 and then once it sustains a move or close above those breakout levels with volume that's near or above 261,916 shares. If that breakout hits soon, then PFMT will set up to re-test or possibly take out its all-time high at $14.09. Any high-volume move above $14.09 will then give PFMT a chance to trend north of $15.
10 Best Managed Healthcare Stocks For 2014: UMH Properties Inc.(UMH)
UMH Properties, Inc. (UMH) is a real estate investment trust. The firm engages in the ownership and operation of manufactured home communities. It leases manufactured home spaces to private manufactured home owners, as well as leases homes to residents. The firm invests in the real estate markets of New York, New Jersey, Pennsylvania, Ohio, and Tennessee. In addition, it invests in debt and equity securities of REITs. United Mobile Homes was incorporated in 1968. The company was formerly known as United Mobile Homes, Inc. UMH Properties is based in Freehold, New Jersey.
Advisors' Opinion:- [By John Udovich]
Trailer parks may have a bad reputation, but Yahoo! Finance�� Breakout segment was recently touting trailer parks as a hot new investment area���meaning its time for retail investors who don�� want to invest in physical parks to start taking a closer look at trailer park stocks Equity Lifestyle Properties, Inc (NYSE: ELS), Sun Communities Inc (NYSE: SUI) and UMH Properties, Inc (NYSE: UMH). According to the segment, roughly 6% of Americans lived in trailer homes as of 2012 with the�supply of designated trailer parks being quite low because no one wants one in their backyard. Anthony Effinger, the author of another article about trailer parks for Bloomberg, was quoted as saying:
No comments:
Post a Comment